Experiments

About this experiment:

Successfully getting a patient started on a new treatment isn’t as easy as just writing a prescription. Almost 30% of patients never fill their first prescription. And half who do, will discontinue use within the first 6 months. So we asked, what if we expanded upon our market ready product Fluent to also support patients throughout these critical first six months.

Fluent 2.0 delivers time-released notifications via mobile apps, txt, email or phone to inform and educate patients on common treatment reactions. Fluent 2.0 answering patient adherence through time-released notifications that inform and educate patients on their treatment’s reactions.

To learn more about Fluent 2.0 or other adherence or mobile applications, contact iQ.

We’d like your feedback:

Please leave a comment below with your suggestions.